好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Sex-specific Cognitive Differences in ALS
Neuromuscular and Clinical Neurophysiology (EMG)
P11 - Poster Session 11 (8:00 AM-9:00 AM)
11-008
To investigate whether cognitive function in ALS patients differs between sexes.
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder exhibiting sexual dimorphism in its epidemiology and clinical presentation. While females typically experience a later onset and a higher incidence of bulbar symptoms, sex differences in cognitive manifestations remain underexplored.
We evaluated 450 individuals with ALS (225 females) for cognitive function, with females and males matched using propensity score matching at a 1:1 ratio for age, site of disease onset, time since disease onset, ALSFRS-R score, and education level. We compared cognitive performances between males and females using an extensive neuropsychological battery. Analyses were performed on cognitively normal subjects and the subgroup of ALS patients with cognitive impairment.
Among ALS patients without overt cognitive impairment, males performed worse than females on verbal memory measures (RAVL-IR -0.76, 95% CI -1.18 to -0.34, P=0.0005; RAVL-DR -1.02, 95% CI -1.46 to -0.58, P<0.0001). Conversely, females exhibited greater deficits in visual memory and visuoconstructive abilities (ROCF-DR -0.37, 95% CI -0.70 to -0.04, P=0.0293; ROCF-IR -0.77, 95% CI -1.47 to -0.07, P=0.0390). These differences persisted in ALS patients with cognitive impairment. Additionally, females with ALS showed a slight, non-significant increase in disinhibition compared to males.
Our findings indicate that cognitive performance in ALS differs between sexes, even when demographic and disease severity variables are matched. Specifically, males with ALS exhibit greater preservation of visuoconstructive abilities, while females show better preservation of verbal memory. These patterns are evident in both cognitively normal and cognitively impaired patients, suggesting that sex-related differences in cognitive impairment may emerge early and persist throughout the disease course. Our data might confirm a role for cognitive reserve mechanisms in ALS.
Authors/Disclosures
Maurizio Grassano, MD (Dept. of Neuroscience, University of Turin)
PRESENTER 		Dr. Grassano has received research support from American Brain Foundation, ALS Association and 好色先生.
Francesca Palumbo (University of Turin Department of Neurosciences: Universita degli Studi di Torin) Dr. Palumbo has nothing to disclose.
Barbara Iazzolino Barbara Iazzolino has nothing to disclose.
Cristina Moglia (University of Torino) Cristina Moglia has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN (Dept. of Neuroscience, University of Turin) Dr. Calvo has nothing to disclose.
Adriano Chio, MD, FAAN (Dept. of Neuroscience, University of Turin) Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.